A Pragmatic Randomized-Controlled Learning Health System Trial
A Pragmatic Randomized-Controlled Learning Health System Trial
To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.
Primary Objective: Evaluate the real-world effectiveness of mPATH-Lung in increasing lung cancer screening rates across diverse populations.
Secondary Objectives
Inclusion Criteria:
Eligible patients will:
Exclusion Criteria:
The following patients will be excluded:
electronic health record Prior history of lung cancer electronic health record Chest CT within the last 12 months electronic health record Those meeting the HEDIS COL-E measure exclusion criteria based on significant comorbidities and/or frailty.
Aliza.randazzo@advocatehealth.org704-355-2000